El dolor irruptivo oncológico o la Cenicienta revelada

• Autores: Yolanda Escobar Álvarez, Dulce Rodríguez Mesa, Jordi J. Moyà Riera, Maite Murillo González
• Localización: Psicooncología: investigación y clínica biopsicosocial en oncología, ISSN 1696-7240, Vol. 10, Nº. 1, 2013 (Ejemplar dedicado a: Investigación y clínica biopsicosocial en oncología), págs. 169-176
• Idioma: español
• DOI: 10.5209/rev_psic.2013.v10.41955
• Enlaces
  • Texto completo
• Referencias bibliográficas
  • 1. Grimm, Jacob & Grimm, Wilhelm. Todos loscuentos de los hermanos Grimm. Ed. Rudolf Steiner & Mandala. 2006.
  • 2. Perrault Charles. La Cenicienta. Ed. Primera Copia, 2011.
  • 3. Davies AN, Dickman A, Reid C, Stevens AM, Zeppetella G. The management of cancer-related breakthrough pain: Recommendations of a task group...
  • 4. Portenoy RK, Hagen NA. Breakthrough pain: Definition, prevalence and characteristics. Pain 1990;41:273-81.
  • 5. Mercadante, S., Radbruch, L., Caraceni, A., Cherny, N., Kaasa, S., Nauck, F., Ripamonti, C., De Conno, F. and Steering Committee of the...
  • 6. Portenoy R K, Forbes K, Lussier D, Hangs G. Difficult pain problems: An integrated approach. En: Doyle D, Hanks G, Cherny N, Calmen K,...
  • 7. Bruno Bettelheim. Psicoanálisis de los cuentos de hadas. Ed. Crítica. 2006.
  • 8. Porta-Sales J, Garzón Rodriguez C, Juliá Torras J, Casals Merchán M. Dolor irruptivo em cáncer. Med Clin (Bar) 2010;135(6):280-5.
  • 9. Greco MT, Corli O, Montanari M, Deandrea S, Zagonel V, Apolone et al. Epidemiology and pattern of care of breakthrough cancer pain in a...
  • 10. Bennett D, Burton AW, Fishman S, Fortner B, McCarberg B, Miaskowski C, et al. Consensus panel recommendations for the assessment and management...
  • 11. Mercadante S. Characteristics and mechanisms of BTCP. Eur J Palliat Care 2010;17 (3):8-12.
  • 12. Zepetella G, Ribeiro MD. Pharmacotherapy of cancer-related episodic pain. Expert Opin Pharmacother 2003;4:493-502. Doi: 10.1517/eoph.4.4.493.22220
  • 13. Hagen NA, Biondo P, Stiles C. Assessment and management of breakthrough pain in câncer patients: Current approaches and emerging research....
  • 14. Laverty DM, Davies A. Assessment. In: Davies A, editor. Cancer-related breakthrough pain. Oxford: Oxford University Press; 2006.p.23-30.
  • 15. Zeppetella G. Succesful management of breakthrough cancer pain. London. Evolving Medicine Ltd 2010.
  • 16. Coluzzi P, Schwartzberg L, Conroy J Charapata S, Gay M, Busch MA, et al. Breakthrough cancer pain: a randomized trial comparing oral transmucosal...
  • 17. Farrar JT, Cleary J, Rauch R Busch M, Nordbrock E . Oral transmucosal fentanyl citrate: randomized, double-blinded, placebo-controlled...
  • 18. Portenoy RK, Taylor D, Messina J, Tremmel L. A randomized, placebo- controlled study of fentanyl buccal tablet for breakthrough pain in...
  • 19. Slatkin NE, Xie F, Messina J, Segal TJ. Fentanyl buccal tablet for relief of breakthrough pain in opioid-tolerant patients with cancer-related...
  • 20. Rauck R, Reynolds L, Geach J, Bull J, Stearns L, Scherlis M, Parikh N, Dillaha L. Efficacy and safety of fentanyl sublingual spray for...
  • 21. Portenoy RP, Burton AW, Gabrail N, Taylor D. Fentanyl Pectin Nasal Spray 043 Study Group. On behalf of the Fentanyl Pectin Nasal Spray...
  • 22. Davies A, Sitte T,Elsner F, Reale C, Espi- nosa J, Brooks D, Fallon M. Consistency of efficacy, patient acceptability, and nasal tolerability...
  • 23. Kress HG, Ororiska A, Kaczmarek Z, Kaasa S, Colberg T, Nolte T. Efficacy and tolerability of intranasal spray 50 to 200 mg for breakthrough...
  • 24. Portenoy RK, Raffaeli W, Torres L Sitte T, Deka AC, Herrera IG et al. Long-term safety, tolerability, and consistency of effect of fentanyl...
  • 25. Hagen NA, Fisher K, Victorino Victorino C Farrar JT. A titration strategy is needed to manage breakthrough cancer pain effectively: Observations...